Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Modin

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Infection|September 20, 2024
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trialJacob Christensen, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
Diabetes, Obesity & Metabolism|April 8, 2024
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Daniel Modin, et al.
American Heart Journal|August 1, 2025
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trialNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Journal of Patient-Reported Outcomes|August 22, 2025
Patient-reported outcomes and home-based self-swabs for influenza-like illness events - lessons learned from the 2023/2024 DANFLU-2 Homeswab PRO substudyFilip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, et al.
NEJM Evidence|February 6, 2024
A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 14, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, et al.
JAMA Cardiology|November 17, 2024
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical TrialsAnkeet S Bhatt, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
The Journal of Infectious Diseases|August 12, 2025
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
European Heart Journal Open|January 15, 2026
Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trialCaroline Espersen, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2024
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trialNiklas Dyrby Johansen, Daniel Modin, Kristoffer Grundtvig Skaarup, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Infection|September 20, 2024
Time of day for vaccination, outcomes, and relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine: A post hoc analysis of the DANFLU-1 randomized clinical trialJacob Christensen, Niklas Dyrby Johansen, Kira Hyldekær Janstrup, et al.
Diabetes, Obesity & Metabolism|April 8, 2024
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Daniel Modin, et al.
American Heart Journal|August 1, 2025
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trialNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.
Journal of Patient-Reported Outcomes|August 22, 2025
Patient-reported outcomes and home-based self-swabs for influenza-like illness events - lessons learned from the 2023/2024 DANFLU-2 Homeswab PRO substudyFilip Soeskov Davidovski, Kristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, et al.
NEJM Evidence|February 6, 2024
A Pragmatic Randomized Feasibility Trial of Influenza VaccinesNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 14, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Older Patients With Hypertension: A Post Hoc Analysis of DANFLU-1Adam Femerling Langhoff, Niklas Dyrby Johansen, Daniel Modin, et al.
JAMA Cardiology|November 17, 2024
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical TrialsAnkeet S Bhatt, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
The Journal of Infectious Diseases|August 12, 2025
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
European Heart Journal Open|January 15, 2026
Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trialCaroline Espersen, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2024
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trialNiklas Dyrby Johansen, Daniel Modin, Kristoffer Grundtvig Skaarup, et al.
Pageof 12